Follow-up after ECT for severe or resistant depression
This observational registry follows short- and longer-term outcomes after electroconvulsive therapy (ECT), including response, side effects, cognition and relapse.
Get research updatesDepression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.
This observational registry follows short- and longer-term outcomes after electroconvulsive therapy (ECT), including response, side effects, cognition and relapse.
DECIDE- Deep Phenotyping for Clinical Inferring Response in Treatment Resistant Depression -Study
Portable Transcranial Magnetic Stimulation (TMS) in a Van for Treatment-Resistant Depression
Functional Neuroimaging of the Enhanced Antidepressant Efficacy of Ketamine in a Biologically-Enriched Subgroup
The Relationship Between Plasma Metabolomics and Proteomics Profiling and Response to Transcranial Magnetic Stimulation Therapy in Treatment-Resistant Depression
A Pilot, Open-label Phase II Trial of Adjunctive Treatment With Ketamine Hydrochloride Prolonged-Release Tablets (KET01) During the Initiation of Antidepressant Therapy in Major Depressive Disorder
This study is no longer accepting new participants.
In LundTreating worry and rumination in individuals with anxiety and depression using Acceptance and Commitment Therapy, measuring symptom reduction, acceptance-based attitudes, level of disability and engagement in valued living
Evaluation of two dietary patterns in people with depression: A proof-of-concept trial
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.